Tvardi Therapeutics Files Q1 2025 10-Q
Ticker: TVRD · Form: 10-Q · Filed: May 13, 2025 · CIK: 1346830
| Field | Detail |
|---|---|
| Company | Tvardi Therapeutics, Inc. (TVRD) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financials
TL;DR
Tvardi Therapeutics (TVRD) Q1 2025 10-Q filed. Financials updated.
AI Summary
Tvardi Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Cara Therapeutics, Inc., is in the pharmaceutical preparations industry. Key financial data points and dates related to its common stock and retained earnings are included in the filing.
Why It Matters
This filing provides investors with an update on Tvardi Therapeutics' financial position and operational status for the first quarter of 2025, crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Tvardi Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the fiscal quarter covered by the report.)
- 2025-05-13 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
- 2834 — SIC Code (Standard Industrial Classification code for Pharmaceutical Preparations.)
Key Players & Entities
- Tvardi Therapeutics, Inc. (company) — Filer of the 10-Q
- Cara Therapeutics, Inc. (company) — Former name of Tvardi Therapeutics, Inc.
- 20250331 (date) — End of the reporting period
- 20250513 (date) — Filing date of the 10-Q
FAQ
What is the primary business of Tvardi Therapeutics, Inc.?
Tvardi Therapeutics, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code 2834.
When was the 10-Q filing for the period ending March 31, 2025, submitted?
The 10-Q filing for the period ending March 31, 2025, was submitted on May 13, 2025.
What was Tvardi Therapeutics, Inc. formerly known as?
Tvardi Therapeutics, Inc. was formerly known as Cara Therapeutics, Inc.
What is the fiscal year end for Tvardi Therapeutics, Inc.?
The fiscal year end for Tvardi Therapeutics, Inc. is December 31.
What is the business address of Tvardi Therapeutics, Inc.?
The business address of Tvardi Therapeutics, Inc. is 3 Sugar Creek Center Blvd., Suite 525, Sugar Land, TX 77478.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Tvardi Therapeutics, Inc. (TVRD).